NCT03100747

Brief Summary

The purpose of this study is to determine whether the rate of post-operative trachomatous trichiasis differs significantly between bilamellar tarsal rotation surgery with an incision height of 3 mm, bilamellar tarsal rotation surgery with an incision height of 5 mm, and Trabut surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,914

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 4, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

April 5, 2017

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2022

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

December 5, 2023

Completed
Last Updated

December 5, 2023

Status Verified

October 1, 2023

Enrollment Period

5.2 years

First QC Date

February 27, 2017

Results QC Date

October 3, 2023

Last Update Submit

December 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Eyes With Presence of Post-Operative Trichiasis Within 12 Months

    Presence of post-operative trichiasis is defined as 1+ trichiatic eyelashes or evidence of recent epilation. Any eyelashes touching the eye with the eye in primary gaze are considered to be trichiatic. Outcomes will be evaluated at 6 weeks and 12 months. The first date of post-operative trichiasis will be used as the outcome.

    12 Months

Secondary Outcomes (11)

  • Number of Eyes With Presence of Post-Operative Trichiasis at 6 Weeks

    6 Weeks

  • Severity of Post-Operative Trichiasis at 6 Weeks

    6 Weeks

  • Severity of Post-Operative Trichiasis at 12 Months

    12 Months

  • Number of Eyes With Presence of Eyelid Contour Abnormalities at 6 Weeks

    6 Weeks

  • Number of Eyes With Presence of Eyelid Contour Abnormalities Within 12 Months

    12 Months

  • +6 more secondary outcomes

Study Arms (3)

Bilamellar 3 mm

ACTIVE COMPARATOR

Bilamellar tarsal rotation trichiasis surgery involves a full-thickness incision through the upper eyelid. For this arm, the height of the incision will be assigned at 3 mm from the eyelid margin.

Procedure: Bilamellar 3 mm

Bilamellar 5mm

ACTIVE COMPARATOR

Bilamellar tarsal rotation trichiasis surgery involves a full-thickness incision through the upper eyelid. For this arm, the height of the incision will be assigned at 5 mm from the eyelid margin.

Procedure: Bilamellar 5 mm

Trabut 3mm

ACTIVE COMPARATOR

Trabut surgery involves a partial-thickness incision through the upper eyelid parallel to the eyelid margin. For this surgery, the height of the incision will be assigned at 3 mm from the eyelid margin.

Procedure: Trabut 3 mm

Interventions

Trichiasis surgery using the bilamellar tarsal rotation procedure with incision 3 mm from the eyelid margin

Also known as: Bilamellar Tarsal Rotation with 3 mm incision
Bilamellar 3 mm

Trichiasis surgery using the bilamellar tarsal rotation procedure with incision 5 mm from the eyelid margin

Also known as: Bilamellar Tarsal Rotation with 5mm incision
Bilamellar 5mm
Trabut 3 mmPROCEDURE

Trichiasis surgery using Trabut procedure with incision 3 mm from the eyelid margin

Also known as: Trabut procedure with 3 mm incision
Trabut 3mm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least one eyelid with previously unoperated upper eyelid trichiasis
  • Willing to comply with all study procedures and be available for the duration of the study

You may not qualify if:

  • Inability to provide independent, informed consent
  • All eyes with previously unoperated trichiasis are phthisical

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orbis Ethiopia

Hosa’ina, Southerns Nations, Nationalities, and Peoples' Region, Ethiopia

Location

Related Publications (3)

  • Gower EW, Sisay A, Bayissasse B, Seyum D, Weaver J, Munoz B, Keil AP, Bankoski A, Sullivan KM, Kana H, Admassu F, Tadesse D, Merbs SL. The impact of modified incision height and surgical procedure on trichiasis surgery outcomes: Results of the maximizing trichiasis surgery success (MTSS) randomized trial. PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012034. doi: 10.1371/journal.pntd.0012034. eCollection 2024 Sep.

  • Diallo AO, Bayissasse B, Sisay A, Seyum D, Weaver J, Munoz B, Merbs SL, Gower EW. Effectiveness of Trachomatous Trichiasis Case-identification Approaches in Ethiopia. Epidemiology. 2023 Nov 1;34(6):909-920. doi: 10.1097/EDE.0000000000001656. Epub 2023 Sep 26.

  • Bayissasse B, Sullivan KM, Merbs SL, Munoz B, Keil A, Sisay A, Singer A, Gower EW. Maximising trichiasis surgery success (MTSS) trial: rationale and design of a randomised controlled trial to improve trachomatous trichiasis surgical outcomes. BMJ Open. 2020 Mar 18;10(3):e036327. doi: 10.1136/bmjopen-2019-036327.

MeSH Terms

Conditions

Trichiasis

Condition Hierarchy (Ancestors)

Eyelid DiseasesEye Diseases

Results Point of Contact

Title
Emily Gower, PhD
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Emily Gower, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2017

First Posted

April 4, 2017

Study Start

April 5, 2017

Primary Completion

June 2, 2022

Study Completion

June 2, 2022

Last Updated

December 5, 2023

Results First Posted

December 5, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Deidentified data will be shared with researchers on an as requested basis after the primary results paper has been published. Interested researchers can contact the principal investigator by email in order to request data and provide a data analysis plan.

Time Frame
9 to 36 months following publication
Access Criteria
Deidentified individual data that supports the results will be shared provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Locations